Header cover image

Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

75 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6492Senhwa BiosciencesNT$95.5023.2%-39.9%NT$8.5bNT$143.00PS15528.5xE32.5%n/a
6576Foresee PharmaceuticalsNT$114.50-0.4%10.6%NT$13.5bNT$130.33PS59.7xE59.8%n/a
3705YungShin Global HoldingNT$42.450.6%-4.1%NT$11.3bn/aPE15.4xn/a4.0%
6733BioGend TherapeuticsNT$26.202.5%-15.8%NT$2.7bn/aPS291.4xn/an/a
6661Welgene BiotechLtdNT$23.001.8%-15.3%NT$530.2mn/aPE39.1xn/a2.1%
1271SunWay BiotechNT$64.60-0.9%3.9%NT$2.2bn/aPE12.7xn/a4.3%
6634Sinew PharmaNT$84.00-3.8%-4.9%NT$5.8bn/aPS931.3xn/an/a
6652EUSOL BiotechNT$9.00-3.2%-66.5%NT$1.2bn/aPB2.8xn/an/a
4130Genovate BiotechnologyNT$25.202.2%-7.7%NT$2.7bn/aPE7283.2xn/a1.4%
4162PharmaEngineNT$87.806.7%19.3%NT$12.6bNT$73.50PE29.6xE16.4%3.1%
4157TaiGen Biopharmaceuticals HoldingsNT$16.50-3.2%-31.4%NT$11.8bn/aPE15.2xn/an/a
1789ScinoPharm TaiwanNT$24.551.2%-9.4%NT$19.4bNT$27.00PE79.7xE61.1%2.0%
4168GlycoNex IncorporationNT$30.00-0.2%-25.5%NT$2.9bn/aPS534.2xn/a0%
6550Polaris GroupNT$128.00-5.2%79.3%NT$92.0bn/aPS6118.5xn/an/a
4172InnoPharmaxNT$16.45-5.2%-7.1%NT$1.4bn/aPS29.7xn/an/a
4160Genetics Generation AdvancementNT$24.700.8%-0.6%NT$598.9mn/aPE76.4xn/a1.2%
6535Lumosa TherapeuticsNT$35.101.3%-6.6%NT$5.7bNT$50.00PE59.7xn/an/a
6586CHO PharmaNT$245.005.4%708.6%NT$41.4bn/aPS12628.9xn/an/a
6645Kim Forest EnterpriseNT$42.8016.5%31.3%NT$1.3bn/aPE44.5xn/a0%
6566Chuang Yi BiotechNT$9.421.3%-40.4%NT$317.3mn/aPS1.2xn/an/a
4747Johnson Chemical Pharmaceutical WorksNT$33.60-2.9%-11.9%NT$1.0bn/aPE20.5xn/a4.3%
1720Standard Chem & PharmNT$42.651.2%7.6%NT$7.6bNT$47.00PE10.8xn/a5.9%
4102Yung Zip Chemical IndNT$21.254.7%-11.6%NT$875.0mn/aPE150xn/a0.5%
6575SyneuRx International (Taiwan)NT$78.806.6%70.2%NT$9.5bn/aPB22.2xn/an/a
Page 2 of 4